RxDoctor Payments Data

Kristina Johnson, MD

Family Medicine · Richmond Hill, GANPI 1841426707

Payments from drug & device makers

$15,530in general payments, 2019–2025

Across 890 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • AbbVie$2K
  • AstraZeneca$2K
  • Lilly USA, LLC$1K
  • Pfizer$923
  • GSK$859
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$15,31299%
  • Education$2181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk152$2,549
AbbVie(2 entities)106$1,698
AstraZeneca(2 entities)78$1,561
Lilly USA, LLC73$1,128
Pfizer58$923
GSK43$859
Boehringer Ingelheim48$838
Amgen(2 entities)34$555
Sanofi-aventis U.S. LLC30$461
Otsuka America Pharmaceutical, Inc.20$419
Esperion Therapeutics, Inc.22$419
Astellas Pharma US Inc15$363
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC21$326
Johnson & Johnson15$264
Bayer13$252
Takeda Pharmaceuticals U.S.A., Inc.13$198
Merck12$189
Bausch Health US, LLC9$164
Biohaven Pharmaceutical Holding Company Ltd.6$138
Antares Pharma, Inc.7$135
Cequr Corporation1$122
Eisai Inc.6$102
Kowa Pharmaceuticals America, Inc.7$99
Phathom Pharmaceuticals, Inc.6$96
Exact Sciences6$92
AMAG Pharmaceuticals, Inc.4$88
Idorsia Pharmaceuticals US Inc5$88
Amarin Pharma, Inc.5$86
Dexcom, Inc.4$80
Lundbeck LLC4$79
Upsher-smith Laboratories LLC5$77
Shield Therapeutics Inc5$76
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$73
Biohaven Pharmaceuticals, Inc.3$72
Novartis4$69
Tolmar, Inc.4$58
Mannkind Corporation3$56
Corium, LLC2$52
Nalpropion Pharmaceuticals LLC3$50
Abbott3$50
IBSA Pharma Inc.3$44
Scilex Pharmaceuticals Inc.2$44
Mckesson Medical-surgical, Inc.2$44
VBI Vaccine (delaware) Inc.2$32
Vanda Pharmaceuticals Inc.1$28
Dermira, Inc.2$28
Evofem Biosciences, Inc.2$28
Currax Pharmaceuticals LLC2$28
Verity Pharmaceuticals Inc.1$25
Clarus Therapeutics Inc.2$25
Ultragenyx Pharmaceutical Inc.1$24
Halozyme Inc1$23
Jazz Pharmaceuticals Inc.1$23
Redhill Biopharma Inc.1$18
Ironshore Pharmaceuticals Inc.1$17
Sumitomo Pharma America, Inc.1$16
Hikma Pharmaceuticals USA1$16
PBG Puerto Rico LLC1$15
Arbor Pharmaceuticals, Inc.1$14
Supernus Pharmaceuticals, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,530 in reported general payments places this provider in the 95th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$89,816
Medicare patients
382
Services billed
1,017

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide90$94,555
FarxigaDapagliflozin Propanediol61$58,162
JardianceEmpagliflozin46$50,595
JanuviaSitagliptin Phosphate43$45,232
MounjaroTirzepatide26$30,681
Diclofenac Sodium34$30,237
VraylarCariprazine Hcl17$25,056
EliquisApixaban27$24,936
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$20,188
Xultophy 100-3.6Insulin Degludec/Liraglutide14$20,076
LinzessLinaclotide13$17,823
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$10,341
Tresiba Flextouch U-200Insulin Degludec12$10,268
Breo ElliptaFluticasone/Vilanterol14$10,175
Dexlansoprazole DrDexlansoprazole12$5,165

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Xultophy 100-3.6$2,549$114,632104 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,561$68,50378 claims
Boehringer IngelheimJardiance$838$50,59546 claims
MerckJanuvia, Dulera$189$48,73454 claims
AbbVieVraylar, Linzess, Synthroid$1,698$46,64376 claims
Lilly USA, LLCMounjaro$1,128$30,68126 claims
GSKTrelegy Ellipta, Breo Ellipta$859$30,36340 claims
PfizerEliquis$923$24,93627 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Richmond Hill

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →